Fulminant type 1 diabetes mellitus after COVID-19 RNA-based vaccine with elevated antibody titer for coxsackievirus B6: A case report and review of the literature

Hisaka Minami; Shinya  Furukawa; Teruki Miyake; Keisho Kurokawa; Yasuhiro Sasaki; Masayuki Nakaishi; Kensuke Nagamatsu; Hiroka Yamago; Naozumi Shibata; Yoichi Hiasa; Bunzo Matsuura

doi:10.22541/au.173641431.19168516/v1

loading page

Fulminant type 1 diabetes mellitus after COVID-19 RNA-based vaccine with elevated antibody titer for coxsackievirus B6: A case report and review of the literature

Hisaka Minami,
Shinya Furukawa,
Teruki Miyake,
Keisho Kurokawa,
Yasuhiro Sasaki,
Masayuki Nakaishi,
Kensuke Nagamatsu,
Hiroka Yamago,
Naozumi Shibata,
Yoichi Hiasa,
Bunzo Matsuura

05 Jan 2025Submitted to Clinical Case Reports

Show details

Hide details

08 Jan 2025Submission Checks Completed

08 Jan 2025Assigned to Editor

22 Jan 2025Reviewer(s) Assigned

Peer review status:UNDER REVIEW